S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NASDAQ:THRN

Thorne HealthTech (THRN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$10.19
$10.19
50-Day Range
$10.13
$10.20
52-Week Range
$3.41
$10.20
Volume
N/A
Average Volume
110,986 shs
Market Capitalization
$549.44 million
P/E Ratio
26.82
Dividend Yield
N/A
Price Target
$8.60
THRN stock logo

About Thorne HealthTech Stock (NASDAQ:THRN)

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.

THRN Stock News Headlines

Dr. Gary A. Thorne
Lisa D. Thorne
The AI Defense Stock Set to Soar
To protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.
Dr. Doris K. Thorne
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Thorne HealthTech Inc
TWOU, OTLY and LWAY among mid-day movers
Update: THRN and FREE, August 9
See More Headlines
Receive THRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Thorne HealthTech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Packaged Foods
Sub-Industry
N/A
Current Symbol
NASDAQ:THRN
Fax
N/A
Employees
544
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.60
High Stock Price Target
$10.20
Low Stock Price Target
$7.00
Potential Upside/Downside
-15.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$15.67 million
Pretax Margin
5.59%

Debt

Sales & Book Value

Annual Sales
$228.73 million
Cash Flow
$0.26 per share
Book Value
$2.78 per share

Miscellaneous

Free Float
13,480,000
Market Cap
$549.44 million
Optionable
Not Optionable
Beta
0.82
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Paul F. Jacobson (Age 68)
    Co-Founder, CEO & Chairman
    Comp: $965k
  • Mr. William C. McCamy (Age 53)
    Pres
    Comp: $478.95k
  • Ms. Saloni S. Varma (Age 44)
    CFO & Director
    Comp: $75k
  • Mr. Thomas P. McKenna (Age 63)
    COO & Director
    Comp: $805.95k
  • Mr. Scott R. Hurth (Age 43)
    Chief Technology Officer
  • Dr. Nathan D. Price Ph.D. (Age 47)
    Chief Scientific Officer & CEO of Onegevity
  • Mr. Thomas Wilson
    VP & Head of Investor Relations
  • Mr. Kim R. Pearson (Age 71)
    Gen. Counsel
  • Ms. Michelle L. Crow (Age 33)
    Chief Marketing Officer
  • Mr. Rob Monteleone
    Sr. VP of Professional Sales

THRN Stock Analysis - Frequently Asked Questions

Should I buy or sell Thorne HealthTech stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Thorne HealthTech in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" THRN shares.
View THRN analyst ratings
or view top-rated stocks.

What is Thorne HealthTech's stock price target for 2024?

2 analysts have issued twelve-month price targets for Thorne HealthTech's stock. Their THRN share price targets range from $7.00 to $10.20. On average, they expect the company's stock price to reach $8.60 in the next year. This suggests that the stock has a possible downside of 15.6%.
View analysts price targets for THRN
or view top-rated stocks among Wall Street analysts.

How were Thorne HealthTech's earnings last quarter?

Thorne HealthTech, Inc. (NASDAQ:THRN) issued its quarterly earnings data on Wednesday, November, 10th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.03. The company had revenue of $48.01 million for the quarter. Thorne HealthTech had a net margin of 7.84% and a trailing twelve-month return on equity of 9.03%.

When did Thorne HealthTech IPO?

Thorne HealthTech (THRN) raised $98 million in an IPO on Thursday, September 23rd 2021. The company issued 7,000,000 shares at a price of $13.00-$15.00 per share.

This page (NASDAQ:THRN) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners